Laura Sutcliffe
Stock Analyst at Citi
(2.68)
# 2,884
Out of 5,014 analysts
497
Total ratings
50.3%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RMD ResMed Inc. | Reiterated: Hold | $33.00 | $31.66 | +4.23% | 24 | Sep 24, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $160.00 | $186.77 | -14.33% | 43 | Sep 23, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $225.00 | $161.00 | +39.75% | 9 | Sep 23, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $31.00 | $15.71 | +97.33% | 40 | Sep 23, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $39.50 | $45.02 | -12.26% | 17 | Sep 10, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $140.00 | $134.86 | +3.81% | 18 | Sep 10, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $49.00 | $55.60 | -11.87% | 18 | Sep 10, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $22.00 | $18.83 | +16.83% | 17 | Sep 10, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $28.01 | $19.18 | +46.03% | 7 | Sep 10, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Upgraded: Buy | $51.00 | $46.04 | +10.77% | 9 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 → $240 | $221.10 | +8.55% | 15 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €40.00 → €34.00 | €26.42 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 86.00 → CHF 84.00 | CHF 119.96 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | €72.64 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.83 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 1,850p → 1,820p | 1,832p | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $35.68 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $142.57 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $958.91 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 → $88 | $29.62 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €108.00 | €138.10 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $41.23 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $48.17 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $303 → $300 | $37.91 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,157.08 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $62.40 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $149.05 | n/a | 14 | Oct 18, 2017 |
ResMed Inc.
Sep 24, 2026
Reiterated: Hold
Price Target: $33.00
Current: $31.66
Upside: +4.23%
CSL Limited
Sep 23, 2026
Reiterated: Hold
Price Target: $160.00
Current: $186.77
Upside: -14.33%
Pro Medicus Limited
Sep 23, 2026
Reiterated: Buy
Price Target: $225.00
Current: $161.00
Upside: +39.75%
Telix Pharmaceuticals Limited
Sep 23, 2026
Reiterated: Buy
Price Target: $31.00
Current: $15.71
Upside: +97.33%
Ansell Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $39.50
Current: $45.02
Upside: -12.26%
Cochlear Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $140.00
Current: $134.86
Upside: +3.81%
Ramsay Health Care Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $49.00
Current: $55.60
Upside: -11.87%
Sonic Healthcare Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $22.00
Current: $18.83
Upside: +16.83%
EBOS Group Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $28.01
Current: $19.18
Upside: +46.03%
Fisher & Paykel Healthcare Corporation Limited
Sep 10, 2026
Upgraded: Buy
Price Target: $51.00
Current: $46.04
Upside: +10.77%
Sep 10, 2026
Reiterated: Hold
Price Target: $235 → $240
Current: $221.10
Upside: +8.55%
May 7, 2024
Reiterated: Hold
Price Target: €40.00 → €34.00
Current: €26.42
Upside: n/a
Dec 14, 2022
Reiterated: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: CHF 119.96
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: €72.64
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $13.83
Upside: n/a
Aug 8, 2022
Reiterated: Hold
Price Target: 1,850p → 1,820p
Current: 1,832p
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $35.68
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $142.57
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $958.91
Upside: n/a
Apr 12, 2021
Reiterated: Hold
Price Target: $85 → $88
Current: $29.62
Upside: n/a
Feb 28, 2020
Reiterated: Hold
Price Target: €108.00
Current: €138.10
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $41.23
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $48.17
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: $303 → $300
Current: $37.91
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,157.08
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $62.40
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $149.05
Upside: n/a